Michael Koutsilieris, MD (Athens), Ph.D (McGill)
Michael Koutsilieris, MD (Athens), Ph.D (McGill)
Professor of Experimental Physiology, Medical School, National and Kapodistrian University of Athens
Verified email at med.uoa.gr
TitleCited byYear
The Akt pathway: molecular targets for anti-cancer drug development
CS Mitsiades, N Mitsiades, M Koutsilieris
Current cancer drug targets 4 (3), 235-256, 2004
2802004
Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS
E Kandaraki, A Chatzigeorgiou, S Livadas, E Palioura, F Economou, ...
The Journal of Clinical Endocrinology & Metabolism 96 (3), E480-E484, 2011
2772011
Muscle regeneration: cellular and molecular events
M Karalaki, S Fili, A Philippou, M Koutsilieris
In vivo 23 (5), 779-796, 2009
2492009
Colorectal cancer stem cells
AG Vaiopoulos, ID Kostakis, M Koutsilieris, AG Papavassiliou
Stem cells 30 (3), 363-371, 2012
2262012
Circadian rhythm disruption in cancer biology
C Savvidis, M Koutsilieris
Molecular medicine 18 (9), 1249-1260, 2012
2202012
Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy
A Philippou, A Halapas, M Maridaki, M Koutsilieris
J Musculoskelet Neuronal Interact 7 (3), 208-218, 2007
1982007
Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy
A Dupont, JL Gomez, L Cusan, M Koutsilieris, F Labrie
The Journal of urology 150 (3), 908-913, 1993
1761993
The role of the insulin-like growth factor-1 system in breast cancer
PF Christopoulos, P Msaouel, M Koutsilieris
Molecular cancer 14 (1), 43, 2015
1632015
The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology
A Philippou, M Maridaki, A Halapas, M Koutsilieris
In Vivo 21 (1), 45-54, 2007
1602007
Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial
A Dupont, M Lemay
Clin. Invest Med 16, 1993
1491993
Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype.
M Koutsilieris, SA Rabbani, HP Bennett, D Goltzman
The Journal of clinical investigation 80 (4), 941-946, 1987
1201987
Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance
Z Panteleakou, P Lembessis, A Sourla, N Pissimissis, A Polyzos, ...
Molecular medicine 15 (3-4), 101-114, 2009
1162009
Osteoblastic metastasis in advanced prostate cancer.
M Koutsilieris
Anticancer Research 13 (2), 443-449, 1993
1151993
Mechanisms of bone metastasis in prostate cancer: clinical implications
P Msaouel, N Pissimissis, A Halapas, M Koutsilieris
Best practice & research Clinical endocrinology & metabolism 22 (2), 341-355, 2008
1132008
The kisspeptin (KiSS-1)/GPR54 system in cancer biology
A Makri, N Pissimissis, P Lembessis, C Polychronakos, M Koutsilieris
Cancer treatment reviews 34 (8), 682-692, 2008
1072008
Type I and II interferon signatures in Sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis
A Nezos, F Gravani, A Tassidou, EK Kapsogeorgou, M Voulgarelis, ...
Journal of autoimmunity 63, 47-58, 2015
1032015
Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro
A Philippou, E Papageorgiou, G Bogdanis, A Halapas, A Sourla, ...
In vivo 23 (4), 567-575, 2009
1032009
Wnt signaling in cardiovascular physiology
K Marinou, C Christodoulides, C Antoniades, M Koutsilieris
Trends in Endocrinology & Metabolism 23 (12), 628-636, 2012
1002012
The role of adiponectin in human vascular physiology
AG Vaiopoulos, K Marinou, C Christodoulides, M Koutsilieris
International journal of cardiology 155 (2), 188-193, 2012
1002012
Mast cell-tumor cell interactions: for or against tumour growth and metastasis?
V Dimitriadou, M Koutsilieris
Anticancer Research 17 (3A), 1541-1549, 1997
971997
The system can't perform the operation now. Try again later.
Articles 1–20